Advanced search
Publication Cover
Substance Abuse Volume 42, 2021 - Issue 4
Journal homepage
460
Views
2
CrossRef citations to date
0
Altmetric
Original Research

“It’s a place that gives me hope”: A qualitative evaluation of a buprenorphine-naloxone group visit program in an urban federally qualified health center

Sunny Laia Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USAView further author information
, MD, MPH,
Erica Lia Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7765-692XView further author information
, MDORCID Icon,
Alexis Silverioa Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USAView further author information
, MPH,
Robin DeBatesb Project HOME Health Services, Philadelphia, Pennsylvania, USAView further author information
, LCSW,
Erin Lee Kellya Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USAView further author information
, PhD &
Lara Carson Weinsteina Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USAView further author information
, MD, MPH, DrPH
Pages 858-864 | Published online: 25 Jan 2021

References

  • Mattick R, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;6(2):CD002207.
  • Jones CM, McCance-Katz EF. Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug Alcohol Depend. 2019;197:78–82.
  • NIDA. Opioid overdose crisis. National Institute on Drug Abuse website. https://www.drugabuse.gov/drug-topics/opioids/opioid-overdose-crisis. Published 2020. Accessed June 17, 2020.
  • Jakubowski A, Fox A. Defining low-threshold buprenorphine treatment. J Addict Med. 2020;14(2):95–98.
  • Reisinger HS, Schwartz RP, Mitchell SG, et al. Premature discharge from methadone treatment: patient perspectives. J Psychoactive Drugs. 2009;41(3):285–296.
  • Winstock AR, Lintzeris N, Lea T. “Should I stay or should I go?” Coming off methadone and buprenorphine treatment?. Int J Drug Policy. 2011;22(1):77–81.
  • Magura S, Rosenblum A. Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored. Mt Sinai J Med. 2001;68(1):62–74.
  • Gryczynski J, Mitchell SG, Jaffe JH, O,Grady KE, Olsen YK, Schwartz RP. Leaving buprenorphine treatment: patients’ reasons for cessation of care. J Subst Abuse Treat. 2014;46(3):356–361.
  • Weinstein LC, Iqbal Q, Cunningham A, et al. Retention of patients with multiple vulnerabilities in a federally qualified health center buprenorphine program: Pennsylvania, 2017-2018. Am J Public Health. 2020;110(4):580–586.
  • Carter J, Zevin B, Lum PJ. Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco. Addict Sci Clin Pract. 2019;14(1):20.
  • Bentzley BS, Barth KS, Back SE, Book SW. Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes. J Subst Abuse Treat. 2015;52:48–57.
  • NIDA. Principles of drug addiction treatment: a research-based guide (third edition). National Institute on Drug Abuse website. https://www.drugabuse.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition. Published 2018. Accessed May 31, 2020.
  • McElrath K. Medication-assisted treatment for opioid addiction in the United States: critique and commentary. Subst Use Misuse. 2018;53(2):334–343.
  • Kourounis G, Richards BDW, Kyprianou E, Symeonidou E, Malliori MM, Samartzis L. Opioid substitution therapy: lowering the treatment thresholds. Drug Alcohol Depend. 2016;161:1–8.
  • Tesema L, Marshall J, Hathaway R, et al. Training in office-based opioid treatment with buprenorphine in US residency programs: a national survey of residency program directors. Subst Abus. 2018;39(4):434–440.
  • Edland-Gryt M, Skatvedt AH. Thresholds in a low-threshold setting: an empirical study of barriers in a centre for people with drug problems and mental health disorders. Int J Drug Policy. 2013;24(3):257–264.
  • Sokol R, Albanese C, Chaponis D, et al. Why use group visits for opioid use disorder treatment in primary care? A patient-centered qualitative study. Subst Abus. 2018;39(1):52–58.
  • Samet JH, Friedmann P, Saitz R. Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Arch Intern Med. 2001;161(1):85–91.
  • Urada D, Teruya C, Gelberg L, Rawson R. Integration of substance use disorder services with primary care: health center surveys and qualitative interviews. Subst Abus Treat Prev Policy. 2014;9(1):1–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.